ABVC BioPharma, Inc. Other than Temporary Impairment Losses, Investments
ABVC BioPharma, Inc. (ABVC) reported Other than Temporary Impairment Losses, Investments of -$2.55 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2019-04-15
- ABVC BioPharma, Inc. other than temporary impairment losses, investments for fiscal 2018 was -$2.55M.
| Period end | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|
| 2018-12-31 | -$2.55M 10-K · filed 2019-04-15 |